BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2937370)

  • 1. Lymphocyte subsets and Langerhans' cells in toxic epidermal necrolysis. Report of a case.
    Merot Y; Gravallese E; Guillén FJ; Murphy GF
    Arch Dermatol; 1986 Apr; 122(4):455-8. PubMed ID: 2937370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine.
    Friedmann PS; Strickland I; Pirmohamed M; Park BK
    Arch Dermatol; 1994 May; 130(5):598-604. PubMed ID: 8179341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell subsets in drug-induced toxic epidermal necrolysis. Possible pathogenic mechanism induced by CD8-positive T cells.
    Miyauchi H; Hosokawa H; Akaeda T; Iba H; Asada Y
    Arch Dermatol; 1991 Jun; 127(6):851-5. PubMed ID: 2036032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperkeratosis lenticularis perstans (Flegel's disease). In situ characterization of T cell subsets and Langerhans' cells.
    Büchner SA
    Acta Derm Venereol; 1988; 68(4):341-5. PubMed ID: 2459881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subsets of keratinocytes and Langerhans' cells express epitopes associated with suppressor-inducer capabilities in resting normal human epidermis.
    De Panfilis G; Manara GC; Ferrari C; Torresani C; Rowden G
    Immunology; 1990 Apr; 69(4):622-5. PubMed ID: 1692305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal lesions of the GVHR: evaluation of the role of different MHC and non MHC loci and of the Ly-2+ and L3T4+ T lymphocytes.
    Piguet PF; Janin-Mercier A; Vassalli P; Saurat JH
    J Immunol; 1987 Jul; 139(2):406-10. PubMed ID: 2955041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lichen planus. Study of the T-lymphocyte population and Langerhans cells using monoclonal antibodies].
    Fernández Bussy RA; Schmitt D; Mauduit G; Gomes MA; Thivolet J
    Med Cutan Ibero Lat Am; 1983; 11(1):17-22. PubMed ID: 6224058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human epidermal cells from ultraviolet light-exposed skin preferentially activate autoreactive CD4+2H4+ suppressor-inducer lymphocytes and CD8+ suppressor/cytotoxic lymphocytes.
    Baadsgaard O; Fox DA; Cooper KD
    J Immunol; 1988 Mar; 140(6):1738-44. PubMed ID: 2964481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption.
    Mizukawa Y; Yamazaki Y; Shiohara T
    Br J Dermatol; 2008 Jun; 158(6):1230-8. PubMed ID: 18363767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Parapsoriasis en plaques. Characterization of the cellular infiltrate using monoclonal antibodies].
    Büchner SA
    Z Hautkr; 1988 May; 63(5):423-4, 427-9. PubMed ID: 3043952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired antigen presentation in toxic epidermal necrolysis.
    Bagot M; Charue D; Heslan M; Wechsler J; Roujeau JC; Revuz J
    Arch Dermatol; 1993 Jun; 129(6):721-7. PubMed ID: 8507074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS; Sharrow SO; Shearer GM
    J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ identification of T lymphocyte subsets and HLA-DR expressing cells in the human skin tuberculin reaction.
    Scheynius A; Klareskog L; Forsum U
    Clin Exp Immunol; 1982 Aug; 49(2):325-30. PubMed ID: 6751638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis.
    Paquet P; Nikkels A; Arrese JE; Vanderkelen A; Piérard GE
    Arch Dermatol; 1994 May; 130(5):605-8. PubMed ID: 8179342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement.
    Correia O; Delgado L; Ramos JP; Resende C; Torrinha JA
    Arch Dermatol; 1993 Apr; 129(4):466-8. PubMed ID: 8466217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pityriasis rosea (Gibert): abnormal distribution pattern of antigen presenting cells in situ.
    Bos JD; Huisman PM; Krieg SR; Faber WR
    Acta Derm Venereol; 1985; 65(2):132-7. PubMed ID: 2408415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell subsets and macrophages in lichen planus. In situ identification using monoclonal antibodies and histochemical techniques.
    Buechner SA
    Dermatologica; 1984; 169(6):325-9. PubMed ID: 6241156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: I. Quantitative analysis of peripheral blood lymphocytes.
    Faure M; Thivolet J
    J Clin Immunol; 1982 Jul; 2(3 Suppl):103S-110S. PubMed ID: 6215423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell subpopulations defined by monoclonal antibodies after HLA-identical sibling marrow transplantation. II. Activated and functional subsets of helper-inducer and cytotoxic-suppressor subpopulations defined by two-colour fluorescence flow cytometry.
    Atkinson K
    Bone Marrow Transplant; 1986 Dec; 1(2):121-32. PubMed ID: 2971408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocytes and Langerhans cells in allergic patch tests.
    Kanerva L; Estlander T; Ranki A
    Derm Beruf Umwelt; 1987; 35(1):17-9. PubMed ID: 2952480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.